Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Nim Stock Analysis Nuveen Select Maturities Municipal Fund Up 0.63 Pct To 9.51 20260401 1 Strt Stock Analysis Strattec Security Corporation 1.87 Dip 78.11 Price Review 20260403 Is Ispecimen Ispc Stock Testing Resistance Price At 0.16 Up 11.11 20260406 Is Super Sle Stock Showing Reversal Signs Price At 3.71 Up 0.54 20260413 Should I Buy Krystal Biotech Krys Stock In 2026 Price At 267.87 Up 1.47 20260408 Advent AVK Stock Worth a Position Unchanged 20260418 The sustainable advantages Strive SATA is developing Unchanged 20260507 Is Montrose MEG stock a strong buy Q4 2025 Profit Disappoints RF Regions Financial Corporation reports Q4 2025 EPS shortfall alongside 62 percent annual revenue growth shares edge higher MidAmerica MAA Stock High Volume Steady Climb 20260420 Mesa Laboratories MLAB Stock Trend Analysis Touches High 20260422 How Gores GTEN management quality shows in execution GTEN Q3 Earnings Gores Stock Volatile Amid DeSPAC Transition Uncertainty HIMX Himax notches slim Q4 2025 EPS beat pushing share prices up more than 10 percent today Hyperfine HYPR Stock Trend Continuation Check Hyperfine posts 387 pct EPS beat with narrower loss Regeneron Pharmaceuticals REGN Otarmeni Gene Therapy Launch Shifts LongTerm Narrative Amid Pipeline Execution Focus How NatWest NWG innovation pipeline shows in financials Q1 2026 Profit Surprises Why Genmab AS GMAB deserves a deeper look right now Breakdown Watch 20260508 Which countries contribute most to Burning Rock BNR revenue Overhead Buying 20260501 How FACT II FACTU pricing power shows up in earnings FACTU QX Earnings No Financial Data Disclosed as Acquisition Search Continues Vince Holding VNCE Delivers Q1 2026 Beat EPS 018 vs 002 Expected EU to Slash Growth Forecasts Hike Inflation Outlook Amid Iran Conflict Stagflation Fears GDP Growth Persists Despite 450 Gas Economic Resilience or Warning Sign Tech and Healthcare Rise as Markets Remain Flat on Low Volume SUNation Energy SUNE Stock Down 399 Support Test at 161 20260515 Lightwave Logic LWLG Slides 1509 as Selling Pressure Mounts 20260518 NextEra Energy to Acquire Dominion Energy Creating the Largest US Electricity Producer Adamas Trust ADAMM Delivers Q1 2026 Beat EPS 040 vs 023 Expected Market Movers SpaceX IPO Speculation Nvidia Earnings and Bezos on AI Bubble Highlight Morning Trading XPeng Inc XPEV Reports Strong Q4 2025 Revenue NA EPS Beats Crude Oil Prices Slide as Market Eyes Diplomatic Progress in Iran Tensions Amicus Therapeutics FOLD Q4 2025 Earnings EPS Misses Estimates Revenue Not Disclosed Shares Unchanged Lumentum Focuses on Execution Amid AI Optical Boom Named IBD Stock of the Day Sebi Bars Seven Entities for Stock Manipulation via Social Media Freezes 20 Crore Gains Berkshire Hathaway Rebuilds Airline Exposure with 26 Billion Delta Stake UK Chancellor Rachel Reeves Unveils VAT Cut on Summer Activities to Ease Cost of Living Pressures UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister FWONA Q4 2025 Earnings Narrow EPS Miss Amid Steady Formula One Operations TSHA Q1 2026 Earnings EPS Miss Highlights Ongoing DevelopmentStage Challenges ADI Q1 2026 Earnings Strong EPS Beat Drives Stock Higher TOI Q1 2026 Earnings Strong Earnings Beat Amidst Limited Revenue Disclosure Ascent Industries Co ACNT Q1 2025 Earnings EPS Misses Estimates Stock Declines Lightspeed Commerce LSPD Gains 3 as Shares Test Key Resistance at 926 OCCIN Preferred Stock Holds Steady at 2476 Trading Near Support Waterdrop Inc WDH Gains 625 as Shares Approach Key Resistance Level Viavi Solutions VIAV Edges Higher Key Levels in Focus After Modest Gains CRANR CraneHbr Rts quarterly earnings data unavailable leadership to share growth outlook in upcoming investor briefing CHTR Charter Q1 earnings miss estimates but shares rally 24 on stable revenue outlook OLB The OLB delivers narrower Q4 2025 loss than forecasts drops 897 percent in todays trading MAMO Massimo Group outlines targeted regional expansion efforts to unlock next phase of revenue growth The opportunity most miss about Kymera Therapeutics KYMR Slight Dip 20260508